Vincent Bollors Media Influence Sparks Debate Over Democracy and EU Intervention
Novartis Upgrades FullYear Outlook on Strong Portfolio Momentum
SpaceX Successfully Launches Starship on Second Attempt Advancing DeepSpace Ambitions
TikTok Goes Dark in US as Trump Signals Potential Intervention Market Uncertainty Looms
Oura Health Files Confidentially for IPO Signaling Potential Public Market Debut
Space Stocks Rally on Renewed SpaceX IPO Speculation
ZVIA Q1 2026 Earnings NarrowerthanExpected Loss Lifts Shares 136
HHS Q2 2025 Earnings Narrowing PerShare Loss Amid Restructuring Efforts
CEVA Q1 2026 Earnings EPS Surges Past Estimates Stock Declines Despite Beat
Teva Q1 2026 Earnings Strong EPS Beat on Cost Discipline Shares Edge Higher
OCFC Q1 2026 Earnings EPS Beats Expectations Amid Modest Share Decline
FFIV Q1 2026 Earnings Strong EPS Beat Despite Stock Decline
Virtus Global MultiSector Income Fund VGI Edges Higher Yield Support Remains Intact
Mondelez International MDLZ Edges Higher as Support Holds But Resistance Caps Gains
Beeline Holdings Inc BLNE Edges Lower Testing Proximity to Key Support
Drugs Made In America Acquisition II Corp Unit DMIIU Holds Steady Near Trust Value Amid Low Volatility
TruBridge TBRG Holds Steady at Key Inflection Point
MYR Group Inc MYRG Surges 39 as Electrical Infrastructure Demand Drives Momentum
Willis Lease Finance WLFC Holds Near Support After Modest Decline
LTRYW Warrants Slip 421 at Penny Levels Key Support and Resistance Both at 001
Commercial Vehicle Group Inc CVGI Rallies as Shares Test Key Resistance Level
Indigo Acquisition Corp Unit INACU Holds Steady at 1028 as SPAC Trading Remains Quiet
Alibaba BABA Faces Resistance Near 136 as Shares Pull Back 119 Technical Levels in Focus
VolitionRx Limited VNRX Gains Attention as TopRated Penny Stock Amid Wall Street Analyst Optimism
MLYS Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Progress Continues
Range Capital Acquisition Corp II RNGT Holds Near 10 Mark Amid Minimal Trading Activity
Heartbeam Inc BEAT Q1 2026 Earnings EPS Surprises to the Upside Amid Revenue Data Absence
Lexaria Bioscience Corp LEXX Q1 2026 Earnings EPS Beat by 38 Despite No Revenue
Cyngn Inc CYN Q1 2026 Earnings EPS Beat Amid Zero Revenue Stock Edges Lower
MSC Q4 2025 Earnings 011 EPS No Revenue Disclosure Stock Declines
INLX Q1 2026 Earnings Significant EPS Miss Amidst Challenging Quarter
BMNR Q1 2026 Earnings EPS Surprise as Company Reports Profitability
DAWN Q4 2025 Earnings WiderThanExpected Loss As PreRevenue Biotech Advances Pipeline